|Bid||56.92 x 1000|
|Ask||56.98 x 800|
|Day's Range||55.07 - 56.99|
|52 Week Range||39.05 - 60.69|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||17.12|
|Earnings Date||Feb 04, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||1.94 (3.51%)|
|Ex-Dividend Date||Dec 31, 2020|
|1y Target Est||61.50|
Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.
Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects.